ATAZANAVIR

Course overview

ATAZANAVIR IS FDA APPROVED FOR TREATING HIV-1 INFECTION, IN COMBINATION WITH OTHER ANTIRETROVIRAL AGENTS, FOR PATIENTS WHO ARE 3-MONTHS-OLD OR OLDER, WEIGHING 5 OR MORE KILOGRAMS. IT IS IN THE PROTEASE INHIBITOR CLASS OF HIV-1 MEDICATIONS. THIS ACTIVITY WILL HIGHLIGHT THE INDICATIONS, MECHANISM OF ACTION, ADMINISTRATION, ADVERSE EFFECTS, CONTRAINDICATIONS, AND MONITORING FOR ATAZANAVIR PERTINENT FOR HEALTHCARE TEAM MEMBERS IN THE MANAGEMENT OF PATIENTS WITH HIV/AIDS.